Rk Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RK PHARMA, and what generic and branded alternatives to RK PHARMA drugs are available?
RK PHARMA has seventeen approved drugs.
There is one tentative approval on RK PHARMA drugs.
Summary for Rk Pharma
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 16 |
| NDAs: | 17 |
Drugs and US Patents for Rk Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rk Pharma | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | TABLET;ORAL | 202337-001 | Jan 20, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rk Pharma | PREGABALIN | pregabalin | CAPSULE;ORAL | 212988-007 | Mar 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rk Pharma | MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 091248-002 | Jan 8, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rk Pharma | PREGABALIN | pregabalin | CAPSULE;ORAL | 212988-006 | Mar 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rk Pharma | URSODIOL | ursodiol | CAPSULE;ORAL | 214329-001 | Jul 28, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rk Pharma | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202493-001 | Jun 18, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
